- Mission [1]
- The goal of the NIH research is to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability,
from the rarest genetic disorder to the common cold. The NIH works toward that mission by utilizing the National Cancer Institute
Clinical Trials and Translational Research Advisory Committee (CTAC). The Committee, which is chaired by the Director of NCI,
conducts and provides oversight and implementation of clinical trials across the Institute. Appointed members of the CTAC
include the Director, NCI as Chair and 25 members. At least five members will hold concurrent membership on either the National
Cancer Advisory Board, Board of Scientific Advisors, Board of Scientific Counselors (Basic Sciences and Clinical Epidemiology),
or Director’s Consumer Liaison Group. Members shall be authorities knowledgeable in the fields of community oncology, surgical
oncology, medical oncology, radiation oncology, patient advocacy, extramural clinical investigation, regulatory agencies,
pharmaceutical industry, public health, clinical trials design, management and evaluation, drug development and developmental
therapeutics, cancer education, cancer information services, community outreach, vaccine development, cellular oncology, molecular
oncology, pediatric oncology, clinical, basic and translational research, cancer center administration, cancer biology and
diagnosis, cancer epidemiology, chemotherapy, community outreach, oncology health care providers, pharmacology, pathology,
biostatistics, quality of life, pain management, cancer treatment and restorative care, and education of health professionals.
|
